Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by eric40on Jul 23, 2017 9:36pm
271 Views
Post# 26499893

RE:RE:Insider Selling

RE:RE:Insider SellingShe is not pocketing 110000$, it is 106000$ left to pay taxes on the 200 000 shares capital gain and the capital gain on 82 000 shares sold. at 12cents, it is a profit of 300 000$ on the option plus probably a profit of another 110 000$ on the 82000 shares sold. For a total of probably around 410 000$ in capital gain triggering a 106 000$ of taxes to pay right away.

So Mme Menard does not pocket a dime but yes she is exchanging 82000 shares at +/- 25 cents for 200 000 shares at a average price of 1,62$.

It is a part of her salary as in every company on the stock market, like it or not.

Of course, now that the taxes is paid, she could sold tomorrow at 1,62$ a share and pocket 324 000$ net . But I am sure that is not going to happen...

Of course It is frustrating to see options being exercises when the SP performance is not what we would like it to be. But that's part of the game. 

Normally, in the next three weeks there should be some news (FDA review type, SRAM deal, Laval Inspection, etc) that  will impact the SP.

Bullboard Posts